期刊文献+

心脑血管疾病危险因子的Meta分析 被引量:25

A Meta-analysis of the risk factors for cardiovascular and cerebrovascular diseases
下载PDF
导出
摘要 目的探讨心脑血管疾病危险因子。方法通过检索Central Cochrane,Medline,CNKI等中英文论文数据库,收集1981年至2009年间公开发表的关于心脑血管疾病危险因素的病例对照研究文献资料,应用Mata分析找出心脑血管疾病的危险因子。结果共检索到相关文献资料102篇,符合Mata分析纳入标准的有54篇,合并有10854例心脑血管疾病患者和43018例健康对照;除饮酒外,吸烟、高血压、糖尿病、家族史、高收缩压、高舒张压、高空腹血糖、血症增高和体质指数超标等确定为有统计学意义的危险因素。结论心脑血管疾病有多重危险因子,需要给予持续的综合干预。 Objective To assess the risk factors for cardiovascular and cerebrovascular diseases by Meta-analysis.Methods A search in Central Cochrane Library,Medline,CNKI and other databases,as to collect placebo-controlled clinical trials(between 1981 and 2009)concerning the risk factors for cardiovascular and cerebrovascular diseases,and Meta-analysis were also performed.Results One hundred and two studies were inclued,fifty four of which selected.10,854 patients with cardiovascular and cerebrovascular diseases were collected as compared with 43,018 controls.It showed that smoking,hypention,diabetes,family history of cardiovascular and cerebrovascular diseases,high systolic pressure,high diastolic pressure,impaired fasting glucose,hyperlipidemia and high body mass index were regarded as risk factors significantly.Conclusion Cardiovascular and cerebrovascular diseases associated with mutilple risk factors that should be controlled.
出处 《中国临床保健杂志》 CAS 2010年第5期463-465,共3页 Chinese Journal of Clinical Healthcare
基金 安徽省科技厅08-09年度重点项目(08020303061)
关键词 心血管疾病 脑血管障碍 危险因素 META分析 Cardiovascular Cerebrovascular Risk factors Meta-analysis
  • 相关文献

参考文献8

二级参考文献36

  • 1Patrick EM,丁国林,胡瑞芬.吸烟对动脉粥样硬化和心血管疾病的病理生理作用[J].国外医学(老年医学分册),1993,14(2):49-51. 被引量:2
  • 2孙旗.血管紧张素受体的分子生物学研究进展[J].国外医学(生理病理科学与临床分册),1994,14(3):134-136. 被引量:2
  • 3许贤文,王海燕.血管紧张素转换酶抑制剂在肾脏疾病中的应用[J].中华医学杂志,1995,75(2):122-134. 被引量:11
  • 4邹阳春,胡大一.低高密度脂蛋白血症与冠心病危险[J].中国医刊,2006,41(3):12-14. 被引量:3
  • 5Sacco RL, Adams R, Albers G, et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline.Circulation, 2006,113 ( 10 ):e409-449. 被引量:1
  • 6Cannon CP, Braunwald E, McCabe CH, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med, 2004,350( 15 ):1495-1504. 被引量:1
  • 7Plakogiannis R, Cohen H. Optimal low-density lipoprotein cholesterol lowering- morning versus evening statin administration. Ann Pharmacother, 2007,41 ( 1 ): 106-110. 被引量:1
  • 8Sever P,Dahlof B,Pouher N, et al. Potential synergy between lipid-lowering and blood-pressure-lowering in the Anglo-Scandinavian Cardiac Outcomes Trial.Eur Heart J, 2006,27 (24):2982-2988. 被引量:1
  • 9Larosa JC, Grundy SM, Waters DD, et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease.N Engl J Med, 2005, 352( 14):1425-1435. 被引量:1
  • 10Kapur NK.Rosuvastatin: a highly potent statin for the prevention and management of coronary artery disease. Expert Rev Cardiovasc Ther, 2007,5(2):161-175. 被引量:1

共引文献17

同被引文献194

引证文献25

二级引证文献115

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部